SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SNRS- Sunrise Technologies
SNRS 0.0000010000.0%Jun 6 11:01 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: majormember who wrote (654)4/9/1998 3:09:00 PM
From: EmuGreg   of 4140
 
A very good point from our friend Sanbag who resides in Yahoo land:

EmuGreg,Skane,SI:sandbagone
Apr 9 1998
2:39PM EDT
In the interest of looking at market penetration, everyone is assuming
that SNRS will be treating hyperopes within the range
of 1-5 diopters. However, I think people should also consider the people above this range who can benefit by the procedure by
bringing their sight from say 7 diopters to 2 diopters. It is my
understanding that this is already being done although not as part
of the clinical data. This opens the market up to those who have a great deal of trouble seeing, to only slightly farsighted. I
believe that the doctors at SNRS are looking at more than they are
publishing. Just a thought.
Regards
sanbag
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News